Ma, Y., Fang, W., Zhang, Y., Yang, Y., Hong, S., Zhao, Y., . . . Zhang, L. (2019). A Phase I/II Open‐Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid Tumors. Oncologist.
Citação norma ChicagoMa, Yuxiang, et al. "A Phase I/II Open‐Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid Tumors." Oncologist 2019.
MLA引文Ma, Yuxiang, et al. "A Phase I/II Open‐Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid Tumors." Oncologist 2019.
警告:這些引文格式不一定是100%准確.